Clinical Trials
56 trialsTissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
BASECAMP-1
A2 Biotherapeutics Inc.
DP-04
AstraZeneca
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
DESCENT-1
A2 Biotherapeutics Inc.
iCaRe2
University of Nebraska
SJFAMILY
St. Jude Children's Research Hospital
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
(CLOCS-2)
Imperial College London
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Memorial Sloan Kettering Cancer Center
OLAP
AstraZeneca
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Yonsei University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
PREFER
Labcorp Corporation of America Holdings, Inc
INSPIRE
Singlera Genomics Inc.
MOHCCN-O
University Health Network, Toronto
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
RADIANT
DxTerity Diagnostics
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
CUSIOS
The Canadian College of Naturopathic Medicine
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
POPCORN
Centro di Riferimento Oncologico - Aviano
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Biologics & Biosimilars Collective Intelligence Consortium
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
CADENCE
MiRXES Pte Ltd
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
WiZen
Technische Universität Dresden
Taiwan Cancer Moonshot Project
Academia Sinica, Taiwan
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
PIONEER
SpeciCare
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
PIPACRegis
University of Magdeburg
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
SPGO Research Mannheim GmbH
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
Edward-Elmhurst Health System